Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
被引:40
|
作者:
Pidala, Joseph
论文数: 0引用数: 0
h-index: 0
机构:
Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Blood & Marrow Transplant Program, Tampa, FL 33612 USA
Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL USAUniv S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Blood & Marrow Transplant Program, Tampa, FL 33612 USA
Pidala, Joseph
[1
,2
]
机构:
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Blood & Marrow Transplant Program, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL USA
Background: Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative therapy with proven efficacy in the management of hematologic malignancies. However, it is complicated by the syndromes of acute and chronic graft-vs-host disease (GVHD). Methods: A narrative review is provided to summarize major biologic insights into the pathogenesis of these immune-mediated disorders, as well as advances in diagnosis, classification, prevention, management, and allied supportive care with the aim of providing essential understanding for clinicians with or without subspecialty experience in the field of blood and marrow transplantation. Results: Major scientific advances have contributed to enhanced understanding of the pathogenesis of these disorders, and clinical investigation has provided more effective preventive and therapeutic strategies for GVHD. However, since acute GVHD and chronic GVHD remain leading sources of transplantation-related morbidity and mortality, ongoing investigation is needed to develop new approaches to addressing these syndromes. Conclusions: The major challenge for future investigation will be to capitalize on biologic insights in order to develop novel strategies for the prevention and therapy of acute and chronic GVHD that will address the current shortcomings in existing therapeutic approaches.
机构:
Ankara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Tekgunduz, Emre
Kaya, Ali Hakan
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Kaya, Ali Hakan
Bozdag, Sinem Civriz
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Univ, Fac Med, Dept Internal Med, Div Hematol, TR-06100 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Bozdag, Sinem Civriz
Kocubaba, Erife
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Kocubaba, Erife
Kayikci, Omur
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Kayikci, Omur
Namdaroglu, Sinem
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Namdaroglu, Sinem
论文数: 引用数:
h-index:
机构:
Ugur, Bilge
论文数: 引用数:
h-index:
机构:
Akpinar, Seval
论文数: 引用数:
h-index:
机构:
Batgi, Hikmetullah
Bekdemir, Filiz
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey
Bekdemir, Filiz
Altuntas, Fevzi
论文数: 0引用数: 0
h-index: 0
机构:
Yildirim Beyazit Univ, Fac Med, Dept Internal Med, Div Hematol, Ankara, TurkeyAnkara Oncol Educ & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey